Event Announcement

Insmed to Present Three Late-Breaking TPIP Abstracts at CHEST 2026

Image
Insmed to Present Three Late-Breaking TPIP Abstracts at CHEST 2026

Bridgewater, N.J. – – October 14, 2026 -- Insmed (Nasdaq: INSM) will present four abstracts on its investigational inhaled therapy treprostinil palmitil inhalation powder (TPIP) at CHEST 2026 in Phoenix, three of them late-breaking, and two ARIKAYCE abstracts at IDWeek 2026 in Washington, D.C. CHEST runs Oct. 18–21 and IDWeek runs Oct. 21–24.

Chief Medical Officer Martina Flammer said the presentations span the company's respiratory portfolio of BRINSUPRI, TPIP and ARIKAYCE.

Serbia Courts Slovenian Business Ahead of EXPO 2027 Belgrade

Ljubljana – October 14, 2026 -- Bilateral goods trade between Serbia and Slovenia reached approximately US$2.04 billion in 2025, according to the Statistical Office of the Republic of Serbia, and EXPO 2027 Belgrade is using that base to recruit Slovenian tourism and business partners.

Visit Serbia event opens ticket sales to travel partners

The Visit Serbia B2B Networking event takes place on 15 October 2026 from 10:30 a.m. to 1:30 p.m. at the InterContinental Ljubljana. It is part of the EXPO 2027 Belgrade international roadshow. The programme introduces the exhibition, officially launches ticket sales for travel partners and includes B2B networking in tourism and business.

Slovenia's pavilion concept will be presented, and the two sides will sign a Memorandum of Cooperation.

UNLEASH 2026 Draws 8,500 Leaders to Paris With Record Ten Sponsors

Image
UNLEASH 2026 Draws 8,500 Leaders to Paris With Record Ten Sponsors

London – October 14, 2026 -- UNLEASH, the HR and future-of-work event organiser, will host 8,500 leaders from 140 countries at the Paris Convention Centre on 20–22 October, backed by a record ten headline sponsors.

Google Cloud joins Docebo, Eightfold, Personio, Phenom, Radancy, SAP SuccessFactors, ServiceNow, Workday and Workhuman on the headline roster. ServiceNow and Personio are new headliners and are making major investments in their UNLEASH partnerships, according to the organiser.

UNLEASH moves to Paris Expo's largest hall in October 2027

The 2026 edition precedes the event's move to Pavilion 1 at Paris Expo Porte de Versailles in October 2027. The venue's largest hall will become the new home of the Paris flagship.

Founder and CEO Marc Coleman said "the question is no longer if AI matters," but which technologies deserve capital and how work design must change.

Beijing Financial Street Forum to Unveil 100+ Outcomes Oct. 19-22

Beijing – October 14, 2026 -- The Annual Conference of Financial Street Forum 2026 will unveil more than 100 outcomes on standards, platforms and open cooperation during October 19-22 in Beijing.

Chinese financial authorities will also release a series of policies on financial reform and development at the event, said Zeng Linfeng, acting head of Xicheng District in Beijing, at a news briefing on Monday.

Conference adds insurance and investment meetings to its agenda

This year's program includes one main forum, several parallel forums and three thematic meetings on fintech, insurance and investment, plus other supporting activities. The insurance and investment meetings are new compared with past sessions. Zeng said they are likely to further reinforce the role of finance in serving the real economy.

Telix Brings 20 Abstracts, 12 Oral Slots to EANM Vienna

Image
Telix Brings 20 Abstracts, 12 Oral Slots to EANM Vienna

Melbourne – October 14, 2026 -- Telix Pharmaceuticals will present 20 company-related abstracts at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM) in Vienna on October 17-21, 2026. Twelve of them were selected for top-rated oral presentations, with the rest running as ePosters.

Three pivotal therapeutic programs lead the oral lineup

The Phase 3 IPAX BrIGHT trial of TLX101-Tx (iodofalan-131I) in recurrent glioblastoma will be presented on October 19 by Nelleke Tolboom of UMC Utrecht. The study tests the therapy with or without lomustine against lomustine alone at first recurrence. The same morning session includes the IODO-RISE study of TLX101-Tx in recurrent high-grade glioma.

Cal Lutheran Sets Nov. 4 Social Media Workshop for Nonprofits

Image
Cal Lutheran Sets Nov. 4 Social Media Workshop for Nonprofits

Thousand Oaks – October 14, 2026 -- California Lutheran University's Center for Nonprofit Leadership will hold a three-hour virtual workshop on social media strategy for nonprofit growth on Wednesday, October 14, 2026, from 9 a.m. to noon, with support from the Santa Barbara Foundation.

Marketing Maven CEO Lindsey Carnett will lead the Zoom session

Carnett, founder and CEO of Marketing Maven, will teach "Strategic Social Media for Nonprofit Growth and Engagement." The session targets nonprofit leaders, communications and marketing staff, and board members. She has more than two decades of marketing and public relations experience, and her specialties include public relations, social media, reputation management, search engine optimization and digital advertising.

Carnett is a Cal Lutheran alumna and a faculty lecturer for the university's Center for Nonprofit Leadership.

EICMA 2026 Fills Ten Halls With 754 Exhibitors, Its Largest Edition

Image
EICMA 2026 Fills Ten Halls With 754 Exhibitors, Its Largest Edition

Milan – October 14, 2026 -- EICMA's 83rd edition will be the largest ever held at Fiera Milano Rho, filling ten exhibition halls over more than 300,000 square metres with 754 exhibitors and 2,120 brands from 52 countries. The hall count is one more than in 2025.

International brands make up 74% of the 2026 exhibitor roster

About 30% of direct exhibitors are either returning companies or first-time participants. EICMA CEO Paolo Magri said the figures show the show's "continuing ability to attract investment" and to welcome new companies.

EICMA.SHIFT UP partnership with MotoGP anchors the exhibition programme

Speed Legends will present more than 30 historic racing motorcycles alongside the five MotoGP bikes competing in 2026, plus interactive experiences and a Gaming Arena. The Dakar Rally returns through a renewed partnership with ASO, bringing historic and modern rally motorcycles and an official Dakar container to Hall 22.

Fesarius to Host DermiSphere Symposium at Plastic Surgery The Meeting

Image
Fesarius to Host DermiSphere Symposium at Plastic Surgery The Meeting

New York – October 14, 2026 -- Fesarius Therapeutics will present its DermiSphereTM hDRT dermal regeneration template at Plastic Surgery The Meeting (PSTM) 2026, October 15–18 at the George R. Brown Convention Center in Houston, Texas. The company will also appear at an event hosted by ASPS Ventures, the medtech venture fund.

Fesarius schedules a one-hour scientific symposium on October 17

The session, "From Benchtop to Bedside - Advancing Dermal Regeneration with Hydrogel Technology," runs 3:30–4:30 p.m. CDT in Innovation Theater B, Exhibit Hall DE. It will cover the science and clinical application of DermiSphereTM hDRT, including its dual-density microarchitecture, recently published clinical data and surgeon experience across complex wound and reconstructive applications.

Summit Napa Pairs AI Labs With Capital Strategy and Brain Science

Image
Summit Napa Pairs AI Labs With Capital Strategy and Brain Science

Napa – October 14, 2026 -- Summit Napa has opened with a program spanning AI, deal-making and brain health, staged by an invitation-only community that reports more than $2.3 billion in capital raised, over 300 Series A through C rounds and over 150 co-founder pairings.

Summit, now part of Events.com, built the event around gathering professionals from business, media, technology, sports and the arts for "conversations that matter," CEO Chris Stakich said. Stakich, formerly chief experience officer at YPO, said the agenda targets people building, scaling and exiting businesses.

AI sessions run through the business track

Brandon Powell, founder and CEO of HatchWorks AI, leads a hands-on session in which attendees build a working AI agent on their own laptops. Geoff Woods leads "The AI-Driven Leader."

Inhibrx Sets Four Oncology Data Presentations Across Three Meetings

Image
Inhibrx Sets Four Oncology Data Presentations Across Three Meetings

San Diego – – October 14, 2026 -- Inhibrx Biosciences (Nasdaq: INBX) will present phase 2 data on both clinical-stage candidates in its pipeline in four sessions at three oncology conferences between Oct. 25 and Nov. 20, 2026.

Ordastobart phase 2 primary analysis goes to ESMO on Oct. 25

The first session is an oral presentation at the European Society for Medical Oncology (ESMO) Congress in Madrid on Sunday, Oct. 25, from 8:30 to 10:00 AM CET. Lead author Jong Chul Park will present the phase 2 primary analysis of HexAgon-HN, a phase 2/3 study of the hexavalent OX40 agonist ordastobart (INBRX-106) combined with pembrolizumab. The trial covers first-line treatment of PD-L1-high recurrent/metastatic head and neck squamous cell carcinoma.